Showing results (131-140 of 257) with videos related to

Sort By:
Pageof 26
Maturitas|May 5, 1999
Micturition complaints in postmenopausal women treated with continuously combined hormone replacement therapy: a prospective studyA L Kok, C W Burger, P H van de Weijer, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1990
Monoclonal antibodies that discriminate between human ovarian carcinomas and benign ovarian tumoursO C Boerman, W K Makkink, C M Thomas, et al.
Cell Biology International Reports|October 1, 1985
Automated counting of human tumour colonies in the Courtenay-Mills assay systemR H Verheijen, R D Whelan, W F Feitz, et al.
American Journal of Obstetrics and Gynecology|September 25, 2001
Raloxifene reduces impedance to flow within the uterine artery in early postmenopausal women: a 2-year randomized, placebo-controlled, comparative studyM S Post, M J van der Mooren, W M van Baal, et al.
Clinical Chemistry|January 1, 1996
Multicenter evaluation of the Abbott IMx CA 15-3 assayG J van Kamp, G G Bon, R A Verstraeten, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1992
Specific and nonspecific immunoassays to detect HAMA after administration of indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibody to patients with ovarian cancerL F Massuger, C M Thomas, M F Segers, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 1, 1988
Clinical applications of monoclonal antibodies against ovarian cancer-associated antigensP Kenemans, C A Yedema, J H Hilgers, et al.
BMJ (Clinical Research Ed.)|July 13, 1996
Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United StatesA Ascherio, E B Rimm, E L Giovannucci, et al.
Atherosclerosis|July 27, 2001
Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among menN F Chu, D Spiegelman, G S Hotamisligil, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1992
The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literatureE M Schutter, J J Visser, G J van Kamp, et al.
Pageof 26